VUKOTIC, Ranka
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.084
EU - Europa 657
AS - Asia 348
SA - Sud America 11
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.076
SE - Svezia 188
GB - Regno Unito 167
HK - Hong Kong 116
CN - Cina 112
IT - Italia 88
SG - Singapore 64
DE - Germania 62
BG - Bulgaria 38
FI - Finlandia 32
UA - Ucraina 20
TR - Turchia 15
CZ - Repubblica Ceca 13
ID - Indonesia 10
CA - Canada 8
RO - Romania 6
BE - Belgio 5
EG - Egitto 5
FR - Francia 5
LT - Lituania 5
NL - Olanda 5
BR - Brasile 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
AT - Austria 3
JP - Giappone 3
KR - Corea 3
MY - Malesia 3
PL - Polonia 3
RU - Federazione Russa 3
VN - Vietnam 3
CH - Svizzera 2
CO - Colombia 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
IN - India 2
IR - Iran 2
PH - Filippine 2
QA - Qatar 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
KW - Kuwait 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.109
Salva come PNG Salva come JPEG
Città #
Fairfield 313
Chandler 302
Ashburn 216
Nyköping 157
Houston 150
Woodbridge 124
Hong Kong 115
Cambridge 108
Southend 104
Wilmington 104
Seattle 94
San Diego 51
Ann Arbor 49
Singapore 48
Dearborn 44
Princeton 41
Sofia 38
Jacksonville 30
Helsinki 28
Modena 25
New York 22
Beijing 21
Redwood City 16
Shanghai 16
Izmir 13
Brno 12
Bremen 10
Nanjing 10
Falls Church 9
Grafing 9
Guangzhou 9
Jakarta 9
Kilburn 9
London 9
Wuhan 9
Augusta 8
Chiswick 8
Eugene 8
Bologna 6
Hounslow 6
Norwalk 6
Toronto 6
Brussels 5
Cairo 5
Munich 5
San Mateo 5
Brooklyn 4
Des Moines 4
San Jose 4
São Paulo 4
Andover 3
Baotou 3
Berlin 3
Boardman 3
Buenos Aires 3
Chicago 3
Kuala Lumpur 3
Santa Rosa 3
Vienna 3
Acton 2
Amsterdam 2
Athens 2
Budrio 2
Dong Ket 2
Dublin 2
Fabriano 2
Frankfurt am Main 2
Glendale 2
Hefei 2
Kemerovo 2
Leawood 2
Lucca 2
Milan 2
Ottawa 2
Palermo 2
Phoenix 2
Sabbio Chiese 2
Salt Lake City 2
San Cesario di Lecce 2
Seongnam 2
Shenzhen 2
Tokyo 2
Wenzhou 2
Worthing 2
Zagreb 2
Zgierz 2
Ardabil 1
Bari 1
Baveno 1
Brandon 1
Brentford 1
Calcinaia 1
Castel Maggiore 1
Central 1
Cilacap 1
Daejeon 1
Doha 1
Doncaster 1
Dubai 1
Dung 1
Totale 2.503
Salva come PNG Salva come JPEG
Nome #
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 227
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 218
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 196
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 169
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 169
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 167
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 165
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 148
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 75
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 75
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 73
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 71
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 69
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 65
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 62
Hepatitis B virus and immune response 61
Clinical and serological profile of primary biliary cirrhosis in men 60
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 60
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 59
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 57
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 56
Familial intrahepatic cholestasis: New and wide perspectives 54
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 53
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 52
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 52
Insights into cancer severity from biomolecular interaction mechanisms 51
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 50
Impact of psychosocial status on liver transplant process 50
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 49
Bone marrow derived stem cells for the treatment of end-stage liver disease 48
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 47
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 46
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 45
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 44
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 43
Hepatitis C Virus Core Antigen (HCVAg): An affordable assay to monitor the efficacy of treatment in DAAs era 43
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 41
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 37
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 35
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 28
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 6
Totale 3.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020333 21 13 4 14 32 83 67 31 30 16 15 7
2020/2021581 23 13 23 43 30 35 24 37 183 24 127 19
2021/2022726 58 30 40 40 16 51 23 87 83 77 123 98
2022/2023746 108 105 69 78 74 114 11 67 81 4 21 14
2023/2024455 21 25 27 70 102 21 43 47 5 6 21 67
2024/202539 39 0 0 0 0 0 0 0 0 0 0 0
Totale 3.176